Assessment of Endothelial Dysfunction With Flow-Mediated Dilatation in Myeloproliferative Disorders
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, cilt.24, sa.7, ss.1102-1108, 2018 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 24 Sayı: 7
- Basım Tarihi: 2018
- Doi Numarası: 10.1177/1076029618766260
- Dergi Adı: CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1102-1108
- Anahtar Kelimeler: flow-mediated dilatation, endothelial dysfunction, myeloproliferative disorders, risk factors, thrombosis, POLYCYTHEMIA-VERA PATIENTS, LOW-DOSE ASPIRIN, ESSENTIAL THROMBOCYTHEMIA, RISK-FACTORS, ACUTE-LEUKEMIA, CD40 LIGAND, THROMBOSIS, NEOPLASMS, COMPLICATIONS, LEUKOCYTOSIS
- Gazi Üniversitesi Adresli: Evet
Özet
Background: Thrombosis is the most important cardiovascular complication of classical myeloproliferative disorders (MPDs). Endothelial dysfunction (ED) is known to play a major role in the mechanism of thrombophilia in MPDs.